We found that specific mutations in KDR, MYC, SIN3B, and NLRC4 appear only in the metastatic setting, while mutations in TP53, TAOK2 and MAP4K2 were also present in the previous samples (original biopsies of the ONB tumor). This evidence concerns the gene MAP4K2 and neoplasm.